Steven DuBois, MD, MS
Director, Experimental Therapeutics
Associate Professor of Pediatrics, Harvard Medical School
Novel agents, Phase 1 clinical trials, Ewing sarcoma, Neuroblastoma, Other pediatric solid tumors
Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Pediatric Hematology/Oncology, 2009
Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology, 2007
University of California, San Francisco School of Medicine, Pediatrics, 2003
University of California, San Francisco School of Medicine, Pediatrics, 2001
University of California, San Francisco School of Medicine, 2000
Dr. DuBois is director of experimental therapeutics at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. He is a pediatric oncologist with an active clinical and translational research program focused on patients with advanced neuroblastoma and Ewing sarcoma. He conducts phase 1 and 2 clinical trials of novel targeted agents. His clinical practice focuses on providing outstanding team-based care for children and young adults with solid cancers.
Dr. Steven DuBois directs the Experimental
Therapeutics Program and the Advancing Childhood Cancer Therapies (ACCT)
clinic, which offers novel early phase clinical trials for children with
relapsed or refractory cancer. Learn more about ACCT.
Video: Meet Steven DuBois
Bringing new treatments to children with cancer
Dr. Steven DuBois oversees testing of new treatments for pediatric patients at Dana-Farber/Boston Children’s. He is working to increase the number of clinical trials available for children and young adults. He specializes in caring for patients with solid tumors such as Ewing sarcoma and neuroblastoma.